Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Assets (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Assets for 16 consecutive years, with $615.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets rose 11.58% to $615.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $615.7 million, a 11.58% increase, with the full-year FY2025 number at $615.7 million, up 11.58% from a year prior.
  • Assets was $615.7 million for Q4 2025 at Lemaitre Vascular, up from $598.1 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $615.7 million in Q4 2025 to a low of $246.5 million in Q2 2021.
  • A 5-year average of $379.8 million and a median of $330.2 million in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: decreased 3.6% in 2021, then skyrocketed 59.13% in 2024.
  • Lemaitre Vascular's Assets stood at $292.8 million in 2021, then rose by 6.04% to $310.5 million in 2022, then rose by 11.69% to $346.8 million in 2023, then surged by 59.13% to $551.8 million in 2024, then increased by 11.58% to $615.7 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Assets are $615.7 million (Q4 2025), $598.1 million (Q3 2025), and $577.6 million (Q2 2025).